Efficacy of trifluridine and tipiracil (tas-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from spain: results of a subgroup analysis of the phase 3 recourse trial

HIGHLIGHTS

• who: F. Longo-Muñoz from the Spain Spain SpainBiomedical Research Institute INCLIVA, University of have published the research: Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial, in the Journal: (JOURNAL)
• what: The current analysis evaluates efficacy and safety of in the RECOURSE Spanish subgroup.

SUMMARY

There were a number of differences in the baseline characteristics of the Spanish population when compared with . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.